ACN three-lens brief
Evidence-based stock research on ACN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 21.0pp over 30 days. · Trading at 4% of its 52-week range — deep in the lower band.
- Trading at 4% of its 52-week range — deep in the lower band.
- Underperforming SPY by 21.0pp over 30 days.
- Analyst mean target $249.19 — 38% above current (26 analysts).
- Debt-to-equity of 25.5 — balance-sheet-heavy.
- 8-K filing filed 2026-04-24.
ACN closed at $180.43 (+0.33%) as of 2026-05-04. Market cap: $111.04B. P/E (trailing) 14.8. Positives: analyst mean target $249.19 — 38% above current (26 analysts).. Concerns: trading at 4% of its 52-week range — deep in the lower band.; underperforming SPY by 21.0pp over 30 days.. Last quarter: Revenue $18.04B, net income $1.83B, free cash flow $12.16B.
Why three lenses on ACN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACNacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ACN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACN brief"></iframe>